These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22248713)

  • 1. National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines.
    Pulsipher MA; Skinner R; McDonald GB; Hingorani S; Armenian SH; Cooke KR; Gracia C; Petryk A; Bhatia S; Bunin N; Nieder ML; Dvorak CC; Sung L; Sanders JE; Kurtzberg J; Baker KS
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):334-47. PubMed ID: 22248713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction.
    Nieder ML; McDonald GB; Kida A; Hingorani S; Armenian SH; Cooke KR; Pulsipher MA; Baker KS
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1573-84. PubMed ID: 21963877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.
    Dietz AC; Mehta PA; Vlachos A; Savage SA; Bresters D; Tolar J; Boulad F; Dalle JH; Bonfim C; de la Fuente J; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
    Biol Blood Marrow Transplant; 2017 May; 23(5):726-735. PubMed ID: 28115275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Shenoy S; Gaziev J; Angelucci E; King A; Bhatia M; Smith A; Bresters D; Haight AE; Duncan CN; de la Fuente J; Dietz AC; Baker KS; Pulsipher MA; Walters MC
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1313-1321. PubMed ID: 29653206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.
    Dietz AC; Savage SA; Vlachos A; Mehta PA; Bresters D; Tolar J; Bonfim C; Dalle JH; de la Fuente J; Skinner R; Boulad F; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1422-1428. PubMed ID: 28533057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies.
    Dietz AC; Duncan CN; Alter BP; Bresters D; Cowan MJ; Notarangelo L; Rosenberg PS; Shenoy S; Skinner R; Walters MC; Wagner J; Baker KS; Pulsipher MA
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):24-29. PubMed ID: 27737772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
    Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Heimall J; Buckley RH; Puck J; Fleisher TA; Gennery AR; Haddad E; Neven B; Slatter M; Roderick S; Baker KS; Dietz AC; Duncan C; Griffith LM; Notarangelo L; Pulsipher MA; Cowan MJ
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1229-1240. PubMed ID: 28479164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.
    Bevans M; El-Jawahri A; Tierney DK; Wiener L; Wood WA; Hoodin F; Kent EE; Jacobsen PB; Lee SJ; Hsieh MM; Denzen EM; Syrjala KL
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):538-551. PubMed ID: 27660168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
    Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):348-71. PubMed ID: 22178693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.
    Dvorak CC; Gracia CR; Sanders JE; Cheng EY; Baker KS; Pulsipher MA; Petryk A
    Biol Blood Marrow Transplant; 2011 Dec; 17(12):1725-38. PubMed ID: 22005649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes.
    Battiwalla M; Hashmi S; Majhail N; Pavletic S; Savani BN; Shelburne N
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):6-9. PubMed ID: 27989931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challenges.
    Bhatia S; Davies SM; Scott Baker K; Pulsipher MA; Hansen JA
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1428-35. PubMed ID: 21763253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.
    Morton LM; Saber W; Baker KS; Barrett AJ; Bhatia S; Engels EA; Gadalla SM; Kleiner DE; Pavletic S; Burns LJ
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):367-378. PubMed ID: 27634019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.
    Schultz RK; Baker KS; Boelens JJ; Bollard CM; Egeler RM; Cowan M; Ladenstein R; Lankester A; Locatelli F; Lawitschka A; Levine JE; Loh M; Nemecek E; Niemeyer C; Prasad VK; Rocha V; Shenoy S; Strahm B; Veys P; Wall D; Bader P; Grupp SA; Pulsipher MA; Peters C
    Biol Blood Marrow Transplant; 2013 Sep; 19(9):1279-87. PubMed ID: 23883618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.
    Rotz SJ; Bhatt NS; Hamilton BK; Duncan C; Aljurf M; Atsuta Y; Beebe K; Buchbinder D; Burkhard P; Carpenter PA; Chaudhri N; Elemary M; Elsawy M; Guilcher GMT; Hamad N; Karduss A; Peric Z; Purtill D; Rizzo D; Rodrigues M; Ostriz MBR; Salooja N; Schoemans H; Seber A; Sharma A; Srivastava A; Stewart SK; Baker KS; Majhail NS; Phelan R
    Bone Marrow Transplant; 2024 Jun; 59(6):717-741. PubMed ID: 38413823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.
    Chow EJ; Anderson L; Baker KS; Bhatia S; Guilcher GM; Huang JT; Pelletier W; Perkins JL; Rivard LS; Schechter T; Shah AJ; Wilson KD; Wong K; Grewal SS; Armenian SH; Meacham LR; Mulrooney DA; Castellino SM
    Biol Blood Marrow Transplant; 2016 May; 22(5):782-95. PubMed ID: 26802323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report.
    Hashmi SK; Bredeson C; Duarte RF; Farnia S; Ferrey S; Fitzhugh C; Flowers MED; Gajewski J; Gastineau D; Greenwald M; Jagasia M; Martin P; Rizzo JD; Schmit-Pokorny K; Majhail NS
    Biol Blood Marrow Transplant; 2017 May; 23(5):717-725. PubMed ID: 27713091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement.
    Di Nardo M; Ahmad AH; Merli P; Zinter MS; Lehman LE; Rowan CM; Steiner ME; Hingorani S; Angelo JR; Abdel-Azim H; Khazal SJ; Shoberu B; McArthur J; Bajwa R; Ghafoor S; Shah SH; Sandhu H; Moody K; Brown BD; Mireles ME; Steppan D; Olson T; Raman L; Bridges B; Duncan CN; Choi SW; Swinford R; Paden M; Fortenberry JD; Peek G; Tissieres P; De Luca D; Locatelli F; Corbacioglu S; Kneyber M; Franceschini A; Nadel S; Kumpf M; Loreti A; Wösten-Van Asperen R; Gawronski O; Brierley J; MacLaren G; Mahadeo KM
    Lancet Child Adolesc Health; 2022 Feb; 6(2):116-128. PubMed ID: 34895512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research.
    Buchbinder D; Brazauskas R; Bo-Subait K; Ballen K; Parsons S; John T; Hahn T; Sharma A; Steinberg A; D'Souza A; Kumar AJ; Yoshimi A; Wirk B; Shaw B; Freytes C; LeMaistre C; Bredeson C; Dandoy C; Almaguer D; Marks DI; Szwajcer D; Hale G; Schouten H; Hashem H; Schoemans H; Murthy HS; Lazarus HM; Cerny J; Tay J; Yared JA; Adekola K; Schultz KR; Lehmann L; Burns L; Aljurf M; Diaz MA; Majhail N; Farhadfar N; Kamble R; Olsson R; Schears R; Seo S; Beattie S; Chhabra S; Savani BN; Badawy S; Ganguly S; Ciurea S; Marino S; Gergis U; Kuwatsuka Y; Inamoto Y; Khera N; Hashmi S; Wood W; Saber W
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):553-561. PubMed ID: 31726205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.